Announcements Trials
Browse Landscape

Phase

Phase 2 4Phase 4 2

Status

Completed 6

Sponsor Class

INDUSTRY 10OTHER 6

Study Type

Interventional 6

Sponsor

Cancer Type

Dermatologic 6Breast 3Thoracic 2Plasma cell 1Genitourinary 1CNS 1

Conditions

Non-melanoma Skin Cancer 2Keratosis, Actinic 2Skin Neoplasms 1Photosensitivity Disorders 1Carcinoma, Basal Cell 1

Interventions

Nivolumab 168Ipilimumab 152pembrolizumab 143Cyclophosphamide 126Interleukin-2 70aldesleukin 69fludarabine phosphate 68Radiotherapy 67Biopsy 53Temozolomide 48Blood Specimen Collection 45Peripheral Blood Stem Cell Transplantation 44fludarabine 43Radiosurgery 40trametinib 38Vemurafenib 36dabrafenib 33sargramostim 32Bevacizumab 31Aminolevulinic Acid 31Magnetic Resonance Spectroscopy 30Mycophenolic Acid 29Specimen Handling 28Whole-Body Irradiation 27Photochemotherapy 26Imiquimod 26CTLA-4 Antigen 26Busulfan 26Tacrolimus 25Surveys and Questionnaires 25

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

6 trials
RecentStart dateEnrollment
OTHER × Diclofenac × Dermatologic × Clear all
NCT02636569 2026-01-21

Topical Chemoprevention of Skin Cancer Biomarkers

University of Alabama at Birmingham

Phase 2 Completed
24 enrolled
Dermatologic

Non-melanoma Skin Cancer

NCT04091022 2025-12-17

Topical Diclofenac and Topical DFMO Chemoprevention Trial in Subjects With a History of Skin Cancer

University of Alabama at Birmingham

Phase 2 Completed
64 enrolled
Dermatologic

Non-melanoma Skin Cancer

NCT00601640 2017-03-23

Eflornithine and/or Diclofenac in Treating Patients With Sun-Damaged Skin

University of Arizona

Phase 2 Completed
184 enrolled 9 charts
Dermatologic

Skin Neoplasms

NCT01935531 2016-03-31

Effects of Topical Diclofenac on Tumor Metabolism

University Hospital Regensburg

Phase 4 Completed
38 enrolled
Dermatologic

Keratosis, Actinic

NCT01358045 2015-01-13

Topical Vitamin D3, Diclofenac or a Combination of Both to Treat Basal Cell Carcinoma

Maastricht University Medical Center

Phase 2 Completed
128 enrolled
Dermatologic

Carcinoma, Basal Cell

NCT00204542 2011-08-19

Comparison of the Efficacy and Tolerability of Solaraze for 3 Versus 6 Months in Patients With Mild to Moderate Actinic Keratosis Located on the Face and Head

University Hospital Tuebingen

Phase 4 Completed
418 enrolled
Dermatologic

Photosensitivity Disorders, Keratosis, Actinic

Data powered by HemOnc (CC BY 4.0) Colophon âš¡